3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Myelodysplastic Syndromes
13
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
7
Multiple Myeloma
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Anemia, Refractory, with Excess of Blasts
5
Lymphoma, Follicular
4
Leukemia, Prolymphocytic
4
Leukemia, Biphenotypic, Acute
4
Waldenstrom Macroglobulinemia
3
Primary Myelofibrosis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, B-Cell, Marginal Zone
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Blast Crisis
3
Recurrence
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Neoplasms
2
Interventions
X-Rays
1
Tablets
1
Sulfonylurea Compounds
1
Standard of Care
1
Sodium-Glucose Transporter 2 Inhibitors
1
Singing
1
Pharmacists
1
Palliative Care
1
Hypnosis
1
Hematologic Tests
1
General Practitioners
1
Exercise
1
Dipeptidyl-Peptidase IV Inhibitors
1
Cyclosporine
1
CIMAvax EGF
1
Blood Specimen Collection
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pulmonary Disease, Chronic Obstructive
×
Cyclosporine
×
1 year
×
Clear all
NCT06892756
2025-09-09
DDI2
Chiesi Farmaceutici S.p.A.
Phase 1
Completed
30 enrolled